These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence? Thomas W; Speer CP Neonatology; 2008; 94(3):150-9. PubMed ID: 18679037 [TBL] [Abstract][Full Text] [Related]
4. Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice. Thomas W; Speer CP Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):264-77. PubMed ID: 17582275 [TBL] [Abstract][Full Text] [Related]
5. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Ambalavanan N; Carlo WA Semin Perinatol; 2006 Aug; 30(4):192-9. PubMed ID: 16860159 [TBL] [Abstract][Full Text] [Related]
7. Ventilatory management and bronchopulmonary dysplasia in preterm infants. Gupta S; Sinha SK; Donn SM Semin Fetal Neonatal Med; 2009 Dec; 14(6):367-73. PubMed ID: 19766071 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia. Baveja R; Christou H Semin Perinatol; 2006 Aug; 30(4):209-18. PubMed ID: 16860161 [TBL] [Abstract][Full Text] [Related]
9. Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models. Rieger-Fackeldey E; Hentschel R J Perinat Med; 2008; 36(5):442-7. PubMed ID: 18605970 [TBL] [Abstract][Full Text] [Related]
10. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Biniwale MA; Ehrenkranz RA Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160 [TBL] [Abstract][Full Text] [Related]
11. A comprehensive approach to the prevention of bronchopulmonary dysplasia. Kugelman A; Durand M Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280 [TBL] [Abstract][Full Text] [Related]
15. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations]. Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322 [TBL] [Abstract][Full Text] [Related]
17. BPD: old and new problems. Mosca F; Colnaghi M; Fumagalli M J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():80-2. PubMed ID: 21892878 [TBL] [Abstract][Full Text] [Related]
18. Nasal respiratory support through the nares: its time has come. Ramanathan R J Perinatol; 2010 Oct; 30 Suppl():S67-72. PubMed ID: 20877411 [TBL] [Abstract][Full Text] [Related]
19. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Van Marter LJ; Leviton A; Kuban KC; Pagano M; Allred EN Pediatrics; 1990 Sep; 86(3):331-6. PubMed ID: 2201940 [TBL] [Abstract][Full Text] [Related]
20. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]